Skip to main content

Table 2 MDA, SOD, GSH-Px concentration and ALT, AST levels in CHC patients before and after the treatment. (Mean ± Standard Deviation)

From: Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy

 

CHC Patients Before Treatment

CHC Patients After treatment

P-value

MDA

9,28 ± 1,61

4,88 ± 1,22

<0.001

CuZn-SOD

213,84 ± 71,61

357,94 ± 82,10

<0.001

GSH-Px

6,52 ± 1,86

9,47 ± 1,82

<0.001

ALT

95.84 ± 22.68

26,73 ± 10,65

<0.001

AST

80.52 ± 19.27

25,52 ± 8,68

<0.001

  1. Values are shown as means, p values (<0.05) were derived by the Paired-Simple T-test Independent Samples T-test. Units were expressed as follows: MDA as nmol/ml; CuZn-SOD as U/ml,; GSH-Px as U/ml; ALT, AST as U/L.